Yulu Qianxing
Divamics Inc. is an interdisciplinary biopharmaceutical company specializing in AI, quantum mechanics, and molecular simulation algorithms to empower drug discovery. It offers a comprehensive drug discovery platform based on multi-scale molecular dynamics and innovative algorithms, providing computational and simulation services including target modeling, druggability analysis, structural screening, design, and optimization. The company focuses on overcoming challenges in designing drugs for undruggable targets by revealing dynamic protein structures and mechanisms. Divamics serves innovative drug enterprises with CRO services across over 20 pipelines, collaborating domestically and internationally, and has been recognized with technology leadership awards and talent projects in Suzhou. Its core MovableType free energy algorithm is endorsed by Nobel laureate Roald Hoffman, positioning Divamics as a leading solution provider in dynamics-based drug discovery.
Yulu Qianxing
Divamics Inc. is an interdisciplinary biopharmaceutical company specializing in AI, quantum mechanics, and molecular simulation algorithms to empower drug discovery. It offers a comprehensive drug discovery platform based on multi-scale molecular dynamics and innovative algorithms, providing computational and simulation services including target modeling, druggability analysis, structural screening, design, and optimization. The company focuses on overcoming challenges in designing drugs for undruggable targets by revealing dynamic protein structures and mechanisms. Divamics serves innovative drug enterprises with CRO services across over 20 pipelines, collaborating domestically and internationally, and has been recognized with technology leadership awards and talent projects in Suzhou. Its core MovableType free energy algorithm is endorsed by Nobel laureate Roald Hoffman, positioning Divamics as a leading solution provider in dynamics-based drug discovery.